First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

This publication has 16 references indexed in Scilit:

• Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
  Transplantation, 2010
• Overview on Clinical Trials and Resistance Breaking Activity of the Anti-Cytomegalovirus Compound AIC246
  Antiviral Research, 2010
• In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
  Antimicrobial Agents and Chemotherapy, 2010
• 189: Subtherapeutic Ganciclovir Levels Result in Resistant CMV in Lung Transplantation Patients
  The Journal of Heart and Lung Transplantation, 2010
• Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
  Clinical Infectious Diseases, 2008
• Resistance to Combined Ganciclovir and Foscarnet Therapy in a Liver Transplant Recipient with Possible Dual-Strain Cytomegalovirus Coinfection
  Liver Transplantation, 2007
• Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
  Clinical Transplantation, 2007
• Clinical impact of ganciclovir‐resistant cytomegalovirus infections in solid organ transplant patients
  Transplant Infectious Disease, 2005
• High Incidence of Ganciclovir‐Resistant Cytomegalovirus Infection among Lung Transplant Recipients Receiving Preemptive Therapy
  The Journal of Infectious Diseases, 2002
• Cytomegalovirus (CMV) Resistance to Antivirals
  American Journal of Transplantation, 2001